01 1DNP Fine Chemicals Utsunomiya Co., Ltd.
02 1Tateyama Chemical Co., Ltd.
01 1Quazepam "Tateyama"
02 1Quazepam (production only)
01 2Japan
Quazepam (for manufacturing purposes only)
Registration Number : 217MF10864
Registrant's Address : 1062-8 Honjo, Nishikata-cho, Tochigi City, Tochigi Prefecture
Initial Date of Registration : 2005-11-01
Latest Date of Registration : 2013-08-14
Registration Number : 217MF10335
Registrant's Address : 1133 Oe, Imizu City, Toyama Prefecture
Initial Date of Registration : 2005-07-21
Latest Date of Registration : 2021-04-13
A Quazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quazepam, including repackagers and relabelers. The FDA regulates Quazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Quazepam supplier is an individual or a company that provides Quazepam active pharmaceutical ingredient (API) or Quazepam finished formulations upon request. The Quazepam suppliers may include Quazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Quazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quazepam Drug Master File in Japan (Quazepam JDMF) empowers Quazepam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quazepam JDMF during the approval evaluation for pharmaceutical products. At the time of Quazepam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quazepam suppliers with JDMF on PharmaCompass.
We have 2 companies offering Quazepam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
